These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2168147)

  • 21. Inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine: implications for the design and discovery of novel antiviral drugs.
    Gasparian AV; Neznanov N; Jha S; Galkin O; Moran JJ; Gudkov AV; Gurova KV; Komar AA
    J Virol; 2010 Sep; 84(18):9390-7. PubMed ID: 20631142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiopyrimidines: specific inhibitors of poliovirus induced early cell damages.
    Marcialis MA; La Colla P; Loddo B
    Experientia; 1972 Sep; 28(9):1117-8. PubMed ID: 4353038
    [No Abstract]   [Full Text] [Related]  

  • 23. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
    Dove AW; Racaniello VR
    J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose.
    Kaluza G; Scholtissek C; Rott R
    J Gen Virol; 1972 Mar; 14(3):251-9. PubMed ID: 4336520
    [No Abstract]   [Full Text] [Related]  

  • 25. Poliovirus coat protein as the site of guanidine action.
    Korant BD
    Virology; 1977 Aug; 81(1):25-36. PubMed ID: 196400
    [No Abstract]   [Full Text] [Related]  

  • 26. Chloroquine induces empty capsid formation during poliovirus eclipse.
    Kronenberger P; Vrijsen R; Boeyé A
    J Virol; 1991 Dec; 65(12):7008-11. PubMed ID: 1658391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution and translation of poliovirus RNA in guanidine-treated cells.
    Caliguiri LA; Tamm I
    Virology; 1968 Oct; 36(2):223-31. PubMed ID: 4300879
    [No Abstract]   [Full Text] [Related]  

  • 28. Further studies on the effect of p-fluorophenylalanine and puromycin on polio virus replication.
    Scharff MD; Summers DF; Levintow L
    Ann N Y Acad Sci; 1965 Jul; 130(1):282-90. PubMed ID: 4285576
    [No Abstract]   [Full Text] [Related]  

  • 29. Early functions of poliovirus. II. The RNA replication of hydroxylamine-inactivated polioviruses.
    Borgert K; Wecker E; Koschel K
    Z Naturforsch B; 1971 Sep; 26(9):934-9. PubMed ID: 4399253
    [No Abstract]   [Full Text] [Related]  

  • 30. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.
    Grant RA; Hiremath CN; Filman DJ; Syed R; Andries K; Hogle JM
    Curr Biol; 1994 Sep; 4(9):784-97. PubMed ID: 7820548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
    Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
    Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antiviral activity of four isothiazole derivatives against poliovirus type 1.
    Pinizzotto MR; Garozzo A; Guerrera F; Castro A; La Rosa MG; Furneri PM; Geremia E
    Antiviral Res; 1992 Jul; 19(1):29-41. PubMed ID: 1332598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete replication of poliovirus in vitro: preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA.
    Barton DJ; Black EP; Flanegan JB
    J Virol; 1995 Sep; 69(9):5516-27. PubMed ID: 7636997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poliovirus-mediated entry of pokeweed antiviral protein.
    Lee T; Crowell M; Shearer MH; Aron GM; Irvin JD
    Antimicrob Agents Chemother; 1990 Oct; 34(10):2034-7. PubMed ID: 1963293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irreversible impairment produced by guanidine on the functions of poliovirus proteins.
    Marcialis MA; Schivo ML; Cioglia AM; Atzeni A; Loddo B
    Experientia; 1973 Dec; 29(12):1561-3. PubMed ID: 4358961
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro antiviral activity of single domain antibody fragments against poliovirus.
    Thys B; Schotte L; Muyldermans S; Wernery U; Hassanzadeh-Ghassabeh G; Rombaut B
    Antiviral Res; 2010 Aug; 87(2):257-64. PubMed ID: 20566349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a capsid-stabilizing pyridazinamine, R 78206, on the eclipse and intracellular location of poliovirus.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    J Virol; 1993 Apr; 67(4):2367-9. PubMed ID: 8383247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of poliovirus replication by N-methylisatin-beta-4':4'-dibutylthiosemicarbazone.
    Pearson GD; Zimmerman EF
    Virology; 1969 Aug; 38(4):641-50. PubMed ID: 4308565
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of poliovirus replication by a plant antiviral peptide.
    Ussery MA; Irvin JD; Hardesty B
    Ann N Y Acad Sci; 1977 Mar; 284():431-40. PubMed ID: 212985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.